TP53 and breast carcinoma: These findings support that genomic evolution occurs at the earliest stages of breast cancer progression (within the ducts) in which driver events including TP53, PIK3CA mutations and HER2 amplifications are present at the DCIS stage, before breaking through the basement membrane of the ducts to establish the invasive disease.